TardiMed Sciences LLC - Sep 2, 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role: 10%+ Owner
Signature: /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Stock symbol: TMBR
Transactions as of: Sep 2, 2021
Transactions value $: -$210,960
Form type: 4
Date filed: 9/2/2021, 07:11 PM
Previous filing: Sep 1, 2021
Next filing: Aug 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMBR	Common Stock, par value $0.001 per share	Sale	-$211K	-225K	-6.03%	$0.94	3.51M	Sep 2, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

TardiMed Sciences LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9011 to $0.9971, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9011 to $0.9971, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.